Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies.
Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.
Roivant Sciences has received investment from 1 venture capital firm.
Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies.
Roivant Sciences has received investment from F-Prime Capital (fka Fidelity Biosciences). These venture capital firms and investors provide both capital and strategic support.
Roivant Sciences was founded in 2014 and is headquartered in New York City as well as major offices in the biotech hubs of Boston and Basel.
Roivant Sciences operates in the Biotech sector. Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies.
